Paul Mola
About Paul Mola
Professional Role at Roswell Biotechnologies
Paul Mola serves as the President, CEO, and Founder of Roswell Biotechnologies. He established the company in 2014. With Roswell Biotechnologies, Paul Mola aims to innovate within the life sciences industry, leveraging his two decades of executive and leadership experience.
Leadership and Executive Experience
Paul Mola possesses over 20 years of leadership and executive experience within the life sciences industry. His roles have spanned various companies and capacities, including his position at Roswell Biotechnologies. Prior to founding Roswell, he was the Head of Global Solutions at Human Longevity, Inc., where he collaborated with genome sequencing pioneer Craig Venter.
Career at Life Technologies / Applied Biosystems
Paul Mola spent over a decade contributing to Life Technologies / Applied Biosystems, which is now part of ThermoFisher Scientific. He held the role of President of the Enterprise Genomic Solutions Business Unit. During his tenure, he received the 'Game Changer' award for his transformative contributions. He led significant projects, including the commercialization of the SOliD sequencing platform and the acquisition of the Ion Torrent sequencing platform.
Achievements in Genomic Programs and Sequencing Technology
Paul Mola has a track record of significant accomplishments within the genomic sector. He established the national genome sequencing program for the government of Saudi Arabia. He also developed the business strategy for the Genia sequencing platform, which was later acquired by Roche. Additionally, he has experience in commercializing sequencing platforms such as SOliD and driving acquisitions like the Ion Torrent platform.
Board Memberships and Advisory Roles
Paul Mola is actively involved in various advisory and board roles. He serves on the board of Biocom California and is a member of the advisory councils to both the Fleet Science Center and the San Diego State University Mission Valley Innovation District.